iSpecimen (ISPC) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Precipio is the larger company by market cap ($41.5 million vs $2.7 million), about 15.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ISPC | PRPO |
|---|---|---|
| Share price | $1.09 | $23.19 |
| Market cap | $2.75M | $41.51M |
| 1-day change | -0.91% | -1.40% |
| YTD return | — | +0.91% |
| 1-year return | — | +26.38% |
| 5-year return | — | -54.71% |
| Forward P/E | — | 59.46 |
| EPS (TTM) | $-52.98 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.60 | $33.63 |
| 52-week low | $1.02 | $16.40 |
| Distance from 52-week high | -97.10% | -31.04% |
| Average volume | 667.50K | 128.13K |
| Shares outstanding | 2.52M | 1.79M |
| Employees | 7 | 61 |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precipio is about 15.1 times larger than iSpecimen by market value ($41.51M vs $2.75M).
About iSpecimen
ISPC stock →iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Healthcare · Diagnostics & Research · 7 employees
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Healthcare · Diagnostics & Research · 61 employees
ISPC vs PRPO FAQ
Which is bigger, iSpecimen or Precipio?
Precipio (PRPO) is larger, with a market capitalization of $41.51M compared with $2.75M for iSpecimen (ISPC).
Are iSpecimen and Precipio in the same industry?
Yes. Both are classified in the Diagnostics & Research industry within the Healthcare sector.